Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Giant corporations are good for compliance

Most of us, if we have any sense at all, harbor some healthy distrust of the world’s biggest companies. For good reason we fear the concentrated power of giant corporations. What, after all, is one person compared to the overwhelming might of Facebook, Walmart, or Exxon?… Continue Reading

UK ends graft investigations of GSK and individuals at Rolls-Royce

The UK Serious Fraud Office said Friday it has closed bribery investigations into UK-based GlaxoSmithKline PLC and individuals at subsidiaries of Rolls-Royce Holdings PLC.

SFO director Lisa Osofsky said in a statement there was “either insufficient evidence to provide a realistic prospect of conviction or it is not in the public interest to bring a prosecution in these cases.”… Continue Reading

Feds open new GSK China bribery investigation

GlaxoSmithKline said in a securities filing Wednesday that the DOJ and SEC asked for information about third-party advisers the company hired in China during a corruption investigation there.

GSK said it is also responding to requests from the SFO for more information about the third parties.… Continue Reading

GSK pays SEC $20 million to settle China FCPA violations

The Securities and Exchange Commission said Friday UK-based pharma GlaxoSmithKline plc will pay a $20 million civil penalty to settle charges that it violated the Foreign Corrupt Practices Act when China-based subsidiaries spent millions of dollars on pay-to-prescribe schemes for several years to pump up sales.… Continue Reading

DOJ indicts China scientists for alleged GSK trade secrets ripoff

The U.S. Attorney’s Office for the Eastern District of Pennsylvania filed an indictment Wednesday charging five people in an alleged scheme to steal trade secrets from pharma giant GlaxoSmithKline. 

The defendants are:

Yu Xue, 45, of Wayne, Pennsylvania

Tao Li, 42, of Nanjing, China

Yan Mei, 36, of Nanjing, China

Tian Xue, 45, of Charlotte, North Carolina, and

Lucy Xi, 38, of West Lake Village, California. … Continue Reading

Peter Humphrey and wife released from prison

British investigator Peter Humphrey and his American wife Yu Yingzeng have been released early from prison in China.
 
Humphrey and Yu were jailed in August last year for illegally obtaining and selling personal information of Chinese citizens.… Continue Reading